Induction chemotherapy and post-remission imatinib therapy for de Novo BCR-ABL-positive AML
Lazarevic, Vladimir LU
; Golovleva, Irina
; Nygren, Ida
and Wahlin, Anders
(2006)
In American Journal of Hematology
81(6).
p.1-470
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/0e0c00ce-d055-4bc0-bb55-c955e7150ab1
- author
- Lazarevic, Vladimir
LU
; Golovleva, Irina
; Nygren, Ida
and Wahlin, Anders
- organization
- publishing date
- 2006-06
- type
- Contribution to journal
- publication status
- published
- subject
- keywords
- Aged, Antineoplastic Agents, Benzamides, Fusion Proteins, bcr-abl, Humans, Imatinib Mesylate, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Male, Piperazines, Pyrimidines, Remission Induction
- in
- American Journal of Hematology
- volume
- 81
- issue
- 6
- pages
- 2 pages
- publisher
- John Wiley & Sons Inc.
- external identifiers
-
- pmid:16680752
- scopus:33646860812
- ISSN
- 0361-8609
- DOI
- 10.1002/ajh.20578
- language
- English
- LU publication?
- yes
- id
- 0e0c00ce-d055-4bc0-bb55-c955e7150ab1
- date added to LUP
- 2016-05-24 17:21:18
- date last changed
- 2024-10-04 20:38:27
@article{0e0c00ce-d055-4bc0-bb55-c955e7150ab1,
author = {{Lazarevic, Vladimir and Golovleva, Irina and Nygren, Ida and Wahlin, Anders}},
issn = {{0361-8609}},
keywords = {{Aged; Antineoplastic Agents; Benzamides; Fusion Proteins, bcr-abl; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Piperazines; Pyrimidines; Remission Induction}},
language = {{eng}},
number = {{6}},
pages = {{1--470}},
publisher = {{John Wiley & Sons Inc.}},
series = {{American Journal of Hematology}},
title = {{Induction chemotherapy and post-remission imatinib therapy for de Novo BCR-ABL-positive AML}},
url = {{http://dx.doi.org/10.1002/ajh.20578}},
doi = {{10.1002/ajh.20578}},
volume = {{81}},
year = {{2006}},
}